You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORIC Sale Disclosure
Heyman Richard A. · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$41.33K
Heyman Richard A. Director
ORIC
Oric Pharmaceuticals
ORIC
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
ORIC daily price context
Close on/before transaction
$12.52
Oct 1, 2026
First close after public filing
$12.49
Oct 5, 2026
30-day return after filing
-27.38%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,200 shares @ $12.91
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001584759-26-000017
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$92.12K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oric Pharmaceuticals, Inc. ORIC | Exercise | Oct 1, 2026 | $5.6K |
| Oric Pharmaceuticals, Inc. ORIC | Sale | Oct 1, 2026 | $45.2K |
| Oric Pharmaceuticals, Inc. ORIC Current | Sale | Oct 1, 2026 | $41.33K |
| Oric Pharmaceuticals, Inc. ORIC | Exercise | Oct 1, 2026 | $0 |